Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

Ai Di Gu; Hao Yuan Mo; Jin Xin Bei; Yan Bo Xie; Li Zhen Chen; Qi Sheng Feng; Tiebang Kang; Yi Xin Zeng

doi:10.1128/CVI.00207-08

Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

Ai Di Gu
, Hao Yuan Mo
, Jin Xin Bei
, Yan Bo Xie
, Li Zhen Chen
, Qi Sheng Feng
, Tiebang Kang
, Yi Xin Zeng

Cancer Center of Sun Yat-Sen University
Departments of Experimental Research

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

Original language	English
Pages (from-to)	592-593
Number of pages	2
Journal	Clinical and Vaccine Immunology
Volume	16
Issue number	4
DOIs	https://doi.org/10.1128/CVI.00207-08
State	Published - Apr 2009
Externally published	Yes

Access to Document

10.1128/CVI.00207-08

Cite this

@article{2ac2d66603604ba8a2ff0ff35a11f8de,

title = "Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma",

abstract = "Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.",

author = "Gu, \{Ai Di\} and Mo, \{Hao Yuan\} and Bei, \{Jin Xin\} and Xie, \{Yan Bo\} and Chen, \{Li Zhen\} and Feng, \{Qi Sheng\} and Tiebang Kang and Zeng, \{Yi Xin\}",

year = "2009",

month = apr,

doi = "10.1128/CVI.00207-08",

language = "英语",

volume = "16",

pages = "592--593",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

AU - Gu, Ai Di

AU - Mo, Hao Yuan

AU - Bei, Jin Xin

AU - Xie, Yan Bo

AU - Chen, Li Zhen

AU - Feng, Qi Sheng

AU - Kang, Tiebang

AU - Zeng, Yi Xin

PY - 2009/4

Y1 - 2009/4

N2 - Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

AB - Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

UR - https://www.scopus.com/pages/publications/64549085963

U2 - 10.1128/CVI.00207-08

DO - 10.1128/CVI.00207-08

M3 - 文章

C2 - 19279168

AN - SCOPUS:64549085963

SN - 1556-6811

VL - 16

SP - 592

EP - 593

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

IS - 4

ER -

Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

Abstract

Access to Document

Other files and links

Fingerprint

Cite this